CARE Ratings Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book
Published 5 Aug 2026 | Capital Markets | Market Cap: ₹5.3K Cr
CARE Ratings aims to consistently outpace industry growth, targeting high double-digit revenue growth in FY '26 and FY '27. The company expects high double-digit revenue growth to continue in FY '26 and FY '27.
From CARE Ratings Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Price
₹1,674
Market Cap
₹5.3K Cr
P/E Ratio
30.7
How does CARE Ratings Ltd rank in Capital Markets?
Compare CARE Ratings Ltd against every Capital Markets company this quarter on revenue, margins and earnings-call signals.
CARE Ratings Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹131 Cr, net profit ₹53 Cr.
Full financials →📊 Revenue & Sales Performance
- →CARE Ratings aims to consistently outpace industry growth, targeting high double-digit revenue growth in FY '26 and FY '27.
- →Growth drivers include expansion across multiple segments such as corporate infra, BFSI, and MCG, with a verticalized business development approach.
- →Non-ratings businesses, including ESG services, analytics, and advisory segments, are scaling up and expected to contribute significantly.
- →Focus on increasing market share in bond and securitization markets continues, supported by robust client onboarding, especially in 'A' and above categories.
- →Digital initiatives like CRM deployment and AI-driven analytics platforms (EdgeAvira.AI) are expected to enhance sales efficiency and product adoption.
- →Despite market uncertainties, robust GDP growth and anticipated private sector capital expenditure are expected to support continued volume and revenue growth.
- →Dividend payouts may see moderation to support strategic investments and cash balance management.
📈 Profitability & Margins
- →The company expects high double-digit revenue growth to continue in FY '26 and FY '27.
- →Profit growth is expected to outpace revenue growth, potentially 1.5 to 2 times the revenue growth rate due to technology and efficiency improvements.
- →Operating margins are likely to remain range-bound as employee costs grow in line with industry benchmarks, ensuring talent retention.
- →Margin expansion similar to pre-2018 levels is not anticipated due to increased investment in skilled personnel.
- →Technology, especially AI, is a key driver for improving operating efficiency and sustaining margins.
- →The growth trajectory aims to outpace industry growth consistently, supported by diversified business segments and pricing improvements.
- →Non-Ratings businesses and subsidiaries are expected to scale up, contributing to consolidated earnings growth.
- →Overall, sustainable margin improvement and robust profit growth are planned, leveraging operating leverage and strategic investments.
🏗️ Capital Expenditure Plans
- →CARE Ratings is focused on strategic investments to scale up non-Rating businesses faster, exploring inorganic opportunities that align with their organically grown segments (Page 14).
- →Investments continue in people and technology, including AI and LLM models, to improve product quality, operational efficiency, and compliance (Pages 6, 7, 13).
- →They are committed to capital allocation balancing talent retention and operating leverage benefits, keeping employee costs controlled while investing in the right skill sets (Page 13).
- →In ESG services, upfront costs and investments are expected, with the company acting as a patient investor to grow this segment sustainably despite initial losses (Pages 11-12).
- →Capital allocation shows a slight dip in dividend payout this year despite high cash balance, with strategic thoughts on free cash flow allocation ongoing (Page 17).
💰 Fundraising & Capital Structure
- →There is no specific mention of any current or planned new fundraising through debt or equity in the document.
- →The focus appears to be on organic growth and scaling up non-Rating businesses.
- →The company is keeping options open for potential inorganic opportunities that fit their business segments and offer synergies but will take decisions at the right time (Page 14).
- →The large cash balance and slight dip in dividend payout raise questions, but management has not detailed strategic thoughts on new capital raising (Page 17).
- →Overall, emphasis is on growth from operational efficiencies, market share gains, and expanding product lines rather than immediate fundraising.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were CARE Ratings Ltd Q4 FY25 results?
CARE Ratings aims to consistently outpace industry growth, targeting high double-digit revenue growth in FY '26 and FY '27. The company expects high double-digit revenue growth to continue in FY '26 and FY '27.
What is CARE Ratings Ltd share price analysis?
CARE Ratings Ltd currently shows a neutral. The stock trades at a P/E of 30.7 with a market cap of ₹5,263 Cr. Investors should review the full earnings analysis for detailed insights.
Is CARE Ratings Ltd planning capital expenditure?
CARE Ratings is focused on strategic investments to scale up non-Rating businesses faster, exploring inorganic opportunities that align with their organically grown segments (Page 14).
Keep CARE Ratings Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.